30
300760.SHE Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
- Market cap
- CNY 224B
- P/E
- 28.9x
- P/B
- 5.35x
- ROE
- 23.2%
- Dividend yield
- 2.51%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300760.SHE undervalued?
Graham number300760.SHE trades 162.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A fundamental analysis
No fundamental analysis for Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A yet.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions in China and internationally. The company offers various products, including patient monitoring, ultrasound, radiology, AED, defibrillation system, anesthesia, CLIA, chemistry, hematology, ventilators, electrocardiograph, endoscope camera system, operating tables, surgical lights, medical supply units, accessories, infusion system, orthopedics, IT Products, cardiovascular intervention, …
Full company profileShenzhen Mindray Bio-Medical Electronics Co Ltd Class A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 9.03B | 11.2B | 13.8B | 16.6B | 21.0B | 25.3B | 30.4B | 34.9B | 36.7B | 33.3B | 36.1B |
| Gross Profit | 5.75B | 7.47B | 9.13B | 10.8B | 13.6B | 16.3B | 19.4B | 22.2B | 23.0B | 20.1B | 22.0B |
| Operating Income | 1.55B | 2.88B | 4.28B | 5.38B | 7.46B | 9.07B | 11.0B | 13.1B | 13.1B | 9.94B | 12.3B |
| EBITDA | 1.61B | 3.48B | 4.38B | 5.39B | 7.73B | 9.38B | 11.2B | 13.2B | 13.7B | 11.4B | 11.3B |
| Net Income | 1.60B | 2.59B | 3.72B | 4.68B | 6.66B | 8.00B | 9.61B | 11.6B | 11.7B | 8.14B | 9.58B |
| EPS | 1.61 | 2.37 | 3.34 | 3.85 | 5.48 | 6.59 | 7.94 | 9.56 | 9.63 | 6.71 | 7.90 |
| Balance Sheet | |||||||||||
| Total Assets | 13.0B | 14.4B | 21.6B | 25.7B | 33.5B | 38.1B | 46.7B | 47.9B | 56.6B | 59.3B | 62.0B |
| Total Liabilities | 8.37B | 7.78B | 6.45B | 7.07B | 10.2B | 11.1B | 14.7B | 14.6B | 15.9B | 16.3B | 15.9B |
| Shareholders' Equity | 4.52B | 6.62B | 15.1B | 18.6B | 23.3B | 27.0B | 32.0B | 33.1B | 35.9B | 38.1B | 41.2B |
| Cash & Short-term Investments | 5.02B | 5.30B | 11.5B | 14.3B | 15.9B | 15.4B | 27.2B | 18.8B | 16.6B | 17.7B | 19.4B |
| Total Debt | 3.54B | 1.80B | 5.85M | 2.22M | 122M | 152M | 139M | 190M | 183M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 3.04B | 3.30B | 4.03B | 4.72B | 8.87B | 9.00B | 12.1B | 11.1B | 12.4B | 10.1B | - |
| Capital Expenditure | 414M | 467M | 678M | 777M | 1.18B | 1.40B | 1.92B | 2.69B | 1.96B | 2.04B | 2.10B |
| Free Cash Flow | 2.63B | 2.83B | 3.36B | 3.94B | 7.69B | 7.60B | 10.2B | 8.37B | 10.5B | 8.11B | 8.97B |
| Ratios | |||||||||||
| ROE | 35.4% | 39.1% | 24.6% | 25.2% | 28.6% | 29.7% | 30.0% | 35.0% | 32.5% | 21.4% | 23.2% |
| ROA | 12.3% | 17.9% | 17.2% | 18.2% | 19.9% | 21.0% | 20.6% | 24.2% | 20.6% | 13.7% | 15.4% |
| Net Profit Margin | 17.7% | 23.2% | 27.0% | 28.3% | 31.7% | 31.7% | 31.6% | 33.2% | 31.8% | 24.4% | 26.5% |
| Debt to Equity | 0.78x | 0.27x | 0.00x | 0.00x | 0.01x | 0.01x | 0.00x | 0.01x | 0.01x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A dividends
- Dividend yield
- 2.51%
- Forward dividend
- 4.24 CNY
- Payout ratio
- 69.0%
- Ex-dividend date
- Nov 9, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 5.61B | 4.63 | 69.0% |
| 2024 | CNY 8.74B | 7.22 | 74.9% |
| 2023 | CNY 10.7B | 8.80 | 92.1% |
| 2022 | CNY 4.23B | 3.50 | 44.1% |
| 2021 | CNY 3.04B | 2.50 | 38.0% |
| 2020 | CNY 1.82B | 1.50 | 27.4% |
| 2019 | CNY 1.22B | 1.00 | 26.0% |
| 2018 | CNY 949M | 0.85 | 25.5% |
| 2017 | CNY 611M | 0.56 | 23.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
- Insiders 56.13%
- Institutions 11.69%
- Public & others 32.17%
- Shares outstanding 1.21B
- Free float 533M
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A company profile
- Company name
- Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
- Ticker
- 300760.SHE
- ISIN
- CNE100003G67
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 21,288
- Fiscal year end
- December
- Address
- Mindray Building, Shenzhen, China, 518057
- Phone
- 86 755 8188 8997
- Website
- mindray.com
About Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions in China and internationally. The company offers various products, including patient monitoring, ultrasound, radiology, AED, defibrillation system, anesthesia, CLIA, chemistry, hematology, ventilators, electrocardiograph, endoscope camera system, operating tables, surgical lights, medical supply units, accessories, infusion system, orthopedics, IT Products, cardiovascular intervention, animal medical, and OEM products. It also provides various solutions, such as M-connect IT, M-connect ER, M-connect ICU, M-connect OR, and M-connect CCU solutions; advanced patient monitoring and intelligent ventilation, emergency ultrasound solutions, and fast defibrillation; customized pendant and critical care ultrasound solutions; precise anesthesia, minimally invasive surgery, infusion system, surgical lights, and anesthesia ultrasound solutions; laboratory diagnostics, medical imaging, and cybersecurity solutions. The company was founded in 1991 and is headquartered in Shenzhen, the People's Republic of China.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A management
10- Mr. Hao WuMD & Director · born 1972
- Ms. Yun ZhaoHead of Finance, Financial Manager & Accounting Supervisor · born 1983
- Ms. Yanmei GuoExecutive Deputy GM & Director · born 1963
- Mr. Zaiwen LiSenior Vice President · born 1974
- Mr. Xinsheng LiSenior Vice President · born 1972
- Ms. Wenzhao LiSecretary of the board · born 1980
- Mr. Laiping LiuDeputy General Manager · born 1970
- Mr. Zhao Yang LiDeputy General Manager · born 1970
- Mr. Jian CenDeputy General Manager · born 1977
- Mr. Xu Jin HeDeputy General Manager · born 1972